ArticleEsophagus : official journal of the Japan Esophageal Society2026
Optimizing lymph node dissection for accurate nodal staging in early-stage esophageal squamous cell carcinoma: a multicenter study.
Article in Esophagus : official journal of the Japan Esophageal Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
backgroundTo confirm the accurate pN0 status in patients with cT1-2N0 esophageal squamous cell carcinoma (ESCC) and recommend an optimal lymph node (LN) count for accurate nodal staging.
methodsA total of 1855 patients who underwent upfront surgery for cT1-2N0 ESCC at two tertiary academic hospitals in Korea between 1995 and 2019 were included. The probability of false-negative lymphadenectomy and the Nodal Staging Score (NSS) were calculated to assess adequate staging.
resultsThe mean age was 63.4 ± 8.0 years, with 93.1% male patients. The mean number of dissected LNs was 34.7 ± 14.0. The clinical T stages were cTis and cT1a 354 (19.1%), cT1b 1,053 (56.8%), and cT2 448 (24.2%). Pathological nodal upstaging occurred in 448 (24.2%) patients, with 337 (18.2%) pN1, 94 (5.1%) pN2, and 17 (0.9%) pN3. The analysis indicated that removing fewer than 33 LNs was associated with a 20% risk of missing metastatic nodes, whereas dissecting 53 nodes reduced this risk to 10%. Although overall survival improved with an increasing number of dissected LNs, the benefits plateaued beyond 33 LNs. The NSS, which indicates the likelihood that a patient with pN0 truly has no occult nodal disease, increased with the number of LNs dissected.
conclusionsWe recommend extensive dissection of at least 33 LNs during esophagectomy for accurate staging and to minimize the risk of undetected positive LNs in early-stage ESCC.
Indexed as
Identifiers
42230511What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.